Abrams P (1997) Urodynamics. Springer, BerlinNewYork Heidelberg
Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167 American College of Surgeons. Committee on T (1997) Advanced trauma life support program for doctors: ATLS. American College of Surgeons, Chicago Anderson JB, Grant JB (1991) Postoperative retention of urine:
a prospective urodynamic study. BMJ 302:894 Anderson JB, Roehrborn CG, Schalken JA et al (2001) The progression of benign prostatic hyperplasia: examining the evidence and determining the risk. Eur Urol 39:390 Andersson KE, Chapple CR, Hofner K (2002) Future drugs for the treatment of benign prostatic hyperplasia. World J Urol 19:436
Andriole G, Bruchovsky N, Chung LW et al (2004) Dihydrotestosterone and the prostate: the scientific rationale for 5-al-pha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol 172:1399 Anjum I, Ahmed M, Azzopardi A et al (1998) Prostatic infarction/infection in acute urinary retention secondary to benign prostatic hyperplasia. J Urol 160:792 Anson KM, Barnes Dg, Briggs TP et al (1993) Temporarypros-tatic stenting and androgen suppression: a new minimally invasive approach to malignant prostatic retention. J R Soc Med 86:634
Caine M, Raz S, Zeigler M (1975) Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 47:193 Chapple CR (2001) Alpha adrenoceptor antagonists in the year
2000: is there anything new? Curr Opin Urol 11:9 Chapple CR (2004) Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician. BJU Int 94:738 Chapple CR, MacDiarmid SA (2000) Urodynamics made easy.
Churchill Livingstone, Edinburgh Chapple CR, Smith D (1994) The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br J Urol 73:117 Choong S, Emberton M (2000) Acute urinary retention. BJU Int 85:186
Chute CG, Stephenson WP, Guess HA et al (1991) Benign prostatic hyperplasia: a population-based study. Eur Urol 20 [Suppl 1]:11
Djavan B, Chapple C, Milani S et al (2004) State ofthe art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 64:1081 Dolin SJ, Cashman JN (2005) Tolerability of acute postoperative pain management: nausea, vomiting, sedation, pruritus, and urinary retention. Evidence from published data. Br J Anaesth 95:584 Elhilali M, Emberton M, Matzkin H et al (2006) Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice. BJU Int 97:513 Emberton M, Anson K (1999) Acute urinary retention in men:
an age old problem. BMJ 318:921 Fitzpatrick JM (2006) The natural history of benign prostatic hyperplasia. BJU Int 97:3 Fitzpatrick JM, Kirby RS (2006) Management of acute urinary retention. BJU Int 97:16 Fong YK, Milani S, Djavan B (2005) Natural history and clinical predictors of clinical progression in benign prostatic hyper-plasia. Curr Opin Urol 15:35 Fowler CJ, Kirby RS (1985) Abnormal electromyographic activity (decelerating burst and complex repetitive discharges) in the striated muscle of the urethral sphincter in 5 women with persisting urinary retention. Br J Urol 57:67 Fowler CJ, Kirby RS, Harrison MJ et al (1984) Individual motor unit analysis in the diagnosis of disorders of urethral sphincter innervation. J Neurol Neurosurg Psychiatry 47: 637
Fowler CJ, Kirby RS, Harrison MJ (1985) Decelerating burst and complex repetitive discharges in the striated muscle of the urethral sphincter, associated with urinary retention in women. J Neurol Neurosurg Psychiatry 48:1004 Girman CJ, Jacobsen SJ, Rhodes T et al (1999) Association of health-related quality of life and benign prostatic enlargement. Eur Urol 35:277 Gnanapragasam VJ, Kumar V, Langton D et al (2006) Outcome of transurethral prostatectomy for the palliative management of lower urinary tract symptoms in men with prostate cancer. Int J Urol 13:711
Goldman HB, Zimmern PE (2006) The treatment of female bladder outlet obstruction. BJU Int 98 [Suppl 1]:17 Jacobsen SJ, Girman CJ, Lieber MM (2001) Natural history of benign prostatic hyperplasia. Urology 58:5 Johansson JE, Andren O, Andersson SO et al (2004) Natural history of early, localized prostate cancer. JAMA 291:2713 Kaplan SA, McConnell JD, Roehrborn CG et al (2006) Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater. J Urol 175:217 Kavia RB, Datta SN, Dasgupta R et al (2006) Urinary retention in women: its causes and management. BJU Int 97:281 Kessler B, Albertsen P (2003) The natural history of prostate cancer. Urol Clin North Am 30:219 Kim JY, Lee SJ, Koo BN et al (2006) The effect of epidural sufen-tanil in ropivacaine on urinary retention in patients undergoing gastrectomy. Br J Anaesth 97:414 Kirby RS (2000) The natural history ofbenign prostatic hyper-plasia: what have we learned in the last decade? Urology 56:3 Kirby RS, McConnell JD (2005) Fast facts: benign prostatic hy-
perplasia. Health Press, Oxford Kurasawa G, Kotani K, Kurasawa M et al (2005) Causes of chronic retention ofurine in the primary care setting. Intern Med 44:761
Leveckis J, Boucher NR, Parys BT et al (1995) Bladder and erectile dysfunction before and after rectal surgeryfor cancer. Br J Urol 76:752
Masumori N, Tsukamoto T, Rhodes T et al (2003) Natural history of lower urinary tract symptoms in men-result of a longitudinal community-based study in Japan. Urology 61:956 McAninch JW, Carroll PR, Jordan GH (1996) Traumatic and reconstructive urology. WB Saunders, Philadelphia McConnell JD, Roehrborn CG, Bautista OM et al (2003) The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hy-perplasia. N Engl J Med 349:2387
McNeill SA, Daruwala PD, Mitchell ID et al (1999) Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled. BJU Int 84:622
Morey AF, Hernandez J, McAninch JW (1999) Reconstructive surgery for trauma of the lower urinary tract. Urol Clin North Am 26:49 Parikh AM, Milroy EJ (1995) Precautions and complications in the use of the UroLume wall stent. Eur Urol 27:1 Patel AK, Chapple CR (2006) Female urethral diverticula. Curr
Opin Urol 16:248 Roehrborn CG (2006a) Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study. BJU Int 97:734 Roehrborn CG (2006b) Definition of at-risk patients: baseline variables. BJU Int 97 [Suppl 2]:7 Roehrborn CG, McConnell JD, Saltzman B et al (2002) Storage (irritative) and voiding (obstructive) symptoms as predictors ofbenign prostatic hyperplasia progression and related outcomes. Eur Urol 42:1 Sandhu DP, Mayor PE, Sambrook PA et al (1992) Outcome and prognostic factors in patients with advanced prostate cancer and obstructive uropathy. Br J Urol 70:412 Singh M, Blandy JP (1976) The pathology of urethral stricture. J Urol 115:673
Thomas K, Chow K, Kirby RS (2004) Acute urinary retention: a review of the aetiology and management. Prostate Cancer Prostatic Dis 7:32 Tuncel A, Uzun B, Eruyar T et al (2005) Do prostatic infarction, prostatic inflammation and prostate morphology play a role in acute urinary retention? Eur Urol 48:277 Weiss RM, George NJR, O'Reilly PH (2001) Comprehensive urology. Mosby, London Wilson TS, Lemack GE, Dmochowski RR (2002) UroLume stents: lessons learned. J Urol 167:2477
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.